Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SEED INNOVATIONS LIMITED AGM Information 2021

Sep 22, 2021

7909_agm-r_2021-09-22_e9218346-1792-4367-9464-3e0ee607a81f.html

AGM Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 6289M

Seed Innovations Limited

22 September 2021

Seed Innovations Ltd / AIM: SEED / Sector: Closed End Investments 

22 September 2021

SEED Innovations Limited ("SEED" or the "Company")

Result of AGM & Updated Investor Presentation

SEED Innovations Ltd, the AIM quoted company investing in fast growing and industry leading businesses with a focus on the medical cannabis, health and wellness space, is pleased to announce that at the Annual General Meeting held earlier today, all resolutions which were proposed to shareholders were duly passed.       

A copy of the Company's updated corporate presentation is now available on the website www.seedinnovations.co

***ENDS***

For further information on the Company please visit  www.seedinnovations.co   or contact:

Ed McDermott /

Lance de Jersey
SEED Innovations Ltd Email:   [email protected]
James Biddle /

Roland Cornish
Beaumont Cornish Limited,

Nomad
Tel: +44 (0) 207 628 3396
Isabella Pierre /

Damon Heath
Shard Capital Partners LLP T: +44 (0)20 7186 9927
Catherine Leftley /

Isabel de Salis
St Brides Partners Ltd,

Financial PR
Email: [email protected]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGFLLFLFKLLBBZ